Chauchat, Laure
Guerin, Camille
Kaluzhny, Yulia
Renard, Jean-Paul
Funding for this research was provided by:
Horus Pharma
Article History
Accepted: 20 August 2023
First Online: 8 September 2023
Declarations
:
: Laure Chauchat and Camille Guerin contributed to study conception, design, and result discussion, and article outlines. All authors reviewed and approved the manuscript. All authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole and have given their approval for this version to be published. The study was sponsored by Horus Pharma (Nice, France).
: Laure Chauchat was employed by Horus Pharma Company. Camille Guerin was employed by Horus Pharma Company. Yulia Kaluzhny was employed by MatTek Life Sciences, a manufacturer of the EpiCorneal tissue model used in the study.
: <i>In vitro</i> experiments were performed on the basis of OECD Guidelines for Testing of Chemicals and the German “Bundesgesetzblatt (BGBI) Chemikaliengesetz” (ChemG, 2013). Animal experiments were performed in accordance with the OECD Principles on good laboratory practice (GLP) and applicable facility Standard Operating Procedures (SOPs), Food and Drug Administration (FDA) and European Medicines Agency (EMA) requirement. All animals were treated according to the Directive 2010/63/UE European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes and to the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research. The registration number with the French Ministry of Research is #12827. This DAP (ethical project authorization request) was authorized by the Ministry on 8 January 2018 (and valid for 5 years). The ethics committee that approved this project is CEEA-087.
: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
: This work has been previously presented at the ARVO Annual Meeting, May 1–4, Denver, CO, 2022.
: Not applicable.
: Not applicable.
: Not applicable.